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LRP4 Mutations Alter Wnt/b-Catenin Signaling
and Cause Limb and Kidney Malformations
in Cenani-Lenz Syndrome
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Cenani-Lenz syndrome (CLS) is an autosomal-recessive congenital disorder affecting distal limb development. It is characterized mainly
by syndactyly and/or oligodactyly and is now shown to be commonly associated with kidney anomalies. We used a homozygosity-
mapping approach to map the CLS1 locus to chromosome 11p11.2-q13.1. By sequencing candidate genes, we identiﬁed recessive
LRP4 mutations in 12 families with CLS. LRP4 belongs to the low-density lipoprotein (LDL) receptor-related proteins (LRPs), which
are essential for various developmental processes. LRP4 is known to antagonize LRP6-mediated activation of canonical Wnt signaling,
a function that is lost by the identiﬁedmutations. Our ﬁndings increase the spectrum of congenital anomalies associated with abnormal
lipoprotein receptor-dependent signaling.Introduction
Spatial and temporal activation of canonical Wnt/b-cate-
nin signaling is an essential developmental process during
organogenesis and tissue regeneration.1 Wnt ligands bind
to their speciﬁc coreceptors, such as frizzled and low-
density lipoprotein-related proteins 5 and 6 (LRP5 [MIM
603506], LRP6 [MIM 603507]), leading to a stabilization
of b-catenin and transcriptional activation.2 Alteration
of the LRP5/6 signaling pathway has been described in
cancer development and human diseases.1,3,4 LRP4 (MIM
604270) is another member of the low-density lipoprotein
receptor family, but has an antagonistic effect on LRP5/6
signaling. Recent results of GWAS in bonemineral density5
and the ﬁnding that Lrp4 serves as a receptor for sclerostin
regulating bone metabolism in mice6 highlight the impor-
tance of LRP4 in the regulation of bone mineral density
and the development of osteoporosis. In mice, Lrp4
dysfunction also causes syndactyly.7
The genetic identiﬁcation of factors regulating limb
formation provided important insights into the role of
major signaling pathways, such as sonic-hedgehog (SHH)
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autosomal-recessive congenital anomaly affecting mainly
distal limb development. CLS is characterized by fusion
and disorganization of metacarpal and phalangeal bones,
radius and ulnar shortening, radioulnar synostosis, and
severe syndactyly of hands and feet.10,11 Kidney hypo-
plasia has been described in one patient with CLS,12 but
is not yet regarded as an associated trait.
Here, we map the CLS1 locus to chromosome 11p11.2-
q13.1 and identify mutations in the LRP4 gene in 12 CLS
families. We show that LRP4 function is required for the
physiological regulation of Wnt signaling, and we identify
mutations that cause loss of LRP4 function, which is
important for normal limb and kidney development.
Therefore, loss of human LRP4 function causes syndactyly,
synostosis, and renal agenesis in Cenani-Lenz syndrome.Material and Methods
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approved by the local institutional review boards. We collected
peripheral blood samples from the affected children and parents,
after informed consent was obtained, according to the protocols
approved by the participating institutions. All of the research
procedures followedwere in accordance with the ethical standards
of the responsible national and institutional committees on
human subject research. Fourteen families with the clinical diag-
nosis of CLS were included in the study. In 12 of them, mutations
were identiﬁed in LRP4. Clinical features of some of the families
have already been published; see families CL-1,12 CL-2,13 CL-3,14
CL-6,15 CL-7.16 DNA from participating family members was
extracted from peripheral blood lymphocytes by standard extrac-
tion procedures.Linkage Analysis
We performed genome-wide linkage analysis in six families (CL-1
to CL-6; not all family members could be initially included into
the genome scan), using the Affymetrix GeneChip Human
Mapping 10K Array (version 2.0). This version of the 10K Chip
Array comprises a total of 10,204 SNPs with a mean intermarker
distance of 258 kb, equivalent to 0.36 cM. Genotypes were called
by the GeneChip DNA Analysis Software (GDAS version 2.0, Affy-
metrix). We veriﬁed sample genders by counting heterozygous
SNPs on the X chromosome. Relationship errors were evaluated
with the help of the program Graphical Relationship Representa-
tion.17 The program PedCheck was applied to detect Mendelian
errors,18 and data for SNPs with such errors were removed from
the data set. Non-Mendelian errors were identiﬁed by use of the
program MERLIN,19 and unlikely genotypes for related samples
were deleted. Nonparametric linkage analysis using all genotypes
of a chromosome simultaneously was carried out with MERLIN.
Parametric linkage analysis was performed by a modiﬁed version
of the program GENEHUNTER 2.120 through stepwise use of
a sliding window with sets of 150 or 300 SNPs. Haplotypes were
reconstructed with GENEHUNTER 2.1 and presented graphically
with HaploPainter.21 This program also reveals informative SNP
markers as points of recombination between parental haplotypes.
All data handling was performed with the use of the graphical user
interface ALOHOMORA,22 developed at the Berlin Gene Mapping
Center to facilitate linkage analysis with chip data.Mutation Screening
We identiﬁed candidate genes in the critical region by using the
ENSEMBL and UCSC human genome databases. We ampliﬁed
the 38 exons of the LRP4 gene (primers are listed in Table S1, avail-
able online) from DNA of index patients from all 14 families and
sequenced the PCR products via the BigDye Terminator method
on an ABI 3100 sequencer. We resequenced all identiﬁed muta-
tions in independent experiments, tested for cosegregation within
the families, and screened at least 200 healthy control individuals
from Turkey, 150 from Pakistan, 50 from Germany, and 50 from
Egypt for each mutation by PCR and/or restriction digestion or
direct sequencing. We analyzed all identiﬁed alterations by using
the server PolyPhen. The LRP4 protein structure was analyzed
with the server Pfam in order to determine different protein
domains of LRP4.cDNA Analysis
RNA was extracted from fresh whole-cell blood through use
of the Paxgene Blood RNA system. After cDNA transcription,
nested PCR was used to amplify LRP4 cDNA (primers are listedThe Amein Table S1). Primers were designed according to the reference
sequence.
Generation of Lrp4 Constructs
Five Lrp4 mutant constructs were generated by site-directed
mutagenesis with the use of wild-type mouse Lrp4 in the
pcDNA3.1/V5-His-TOPO vector (Invitrogen, Karlsruhe, Germany)
as template. The correct sequence of all PCR amplicons and
constructs was conﬁrmed by direct sequencing from both sides
with the use of the ABI BigDye Terminator v1.1 Cycle Sequencing
Kit and the ABI 3730 DNA Analyzer (Applied Biosystems, Foster
City, CA, USA).
Cell Culture and Transfections
Human embryonic kidney (HEK)293T cells were cultured in Dul-
becco’s Modiﬁed Eagle Media (DMEM) containing 10% fetal
bovine serum (FBS), amphothericin B, streptomycin, and peni-
cillin. Cells were transfected with the use of Lipofectamine 2000
(Invitrogen, Karlsruhe, Germany) according to the manufacturer’s
instructions.
Luciferase Assay
One day before transfection, approx. 400.000 HEK293T cells were
plated out in 12-well plates and grown up to 50% conﬂuency in
10% FBS and DMEM. Transfections were performed in triplicate
with the use of the TOP-Flash reporter system and the indicated
expression plasmids with the following concentrations: 500 ng
wild-type (WT) Lrp4 or 500 ng mutants, 250 ng Lrp6, 250 ng
Wnt1, 100 ng Topﬂash Vector, 5 ng Renilla (p-RL-TK). Cells were
transfected with the use of Lipofectamine 2000 (Invitrogen, Karls-
ruhe, Germany) according to themanufacturer’s instructions. Two
days after transfection, cells were lysed and Luciferase activity was
measured with the use of the Dual-Luciferase Reporter Assay Kit
and a Glomex 96-microplate luminometer (Promega, Mannheim,
Germany). Each transfection was also measured in triplicate.
Immunoblot
Immunoblot analysis was performed according to standard proto-
cols. Detection of LRP4 was conducted with a C-terminal Lrp4
mouse monoclonal antibody (1:1000).
Cell-Surface Biotin-Labeling Assay
One day before the experiment, 50% conﬂuent HEK293T cells
were cotransfected with 1.5 mg LRP4, WT or mutant, and 1.5 mg
insulin receptor (IR) in T75 cm2 ﬂasks. Biotinylation was carried
out with the use of the Cell Surface Protein Isolation Kit (Pierce,
Bonn, Germany) according to the manufacturer’s instructions.
Protein concentrations were measured with the use of the BCA
Protein Assay Kit (Pierce). Immunoblot analysis was performed
according to standard protocols. Detection of LRP4 and IR was
conducted with a C-terminal LRP4 mouse monoclonal antibody
(1:1000) and an insulin-receptor rabbit monoclonal antibody
(Abcam, Berlin, Germany) (1:1000).Results
Clinical Findings in CLS Families
We have examined 14 CLS families presenting with a vari-
able expression of clinical symptoms. In twelve of themwe
identiﬁed the molecular basis of the disease (Figure 1A,rican Journal of Human Genetics 86, 696–706, May 14, 2010 697
Figure 1. Clinical Findings in Families with CLS and Mapping of the CLS1 Locus
(A) Typical hand and feet anomalies seen in CLS patients.
(B) Graphical view of additive LOD-score calculations of genome-wide SNPmapping in families CL-1 to CL-6. Ideogram of chromosome
11 showing the localization of linked region.
(C) Haplotypes of CLS families included in the initial linkage analysis.Table 1). We observed mild facial dysmorphism in the
majority of CLS cases, with prominent forehead, hyperte-
lorism, downslanting palpebral ﬁssures, andmicrognathia.
Typical limb malformations included total to partial
syndactyly of hands and feet, as well as distal bone malfor-
mations affecting the radius and ulna as well as the meta-
carpal and phalangeal bones (Figure 1A, Table 1). Interest-
ingly, we also found kidney anomalies, including renal
agenesis and hypoplasia, in over 50% of CLS families.
Mapping of the CLS1 Locus and Identiﬁcation
of LRP4 Mutations
Initially, we genotyped DNA samples from six CLS families
(CL-1 to CL-6, Figure 1) by using the Affymetrix GeneChip
Human Mapping 10K Array. Affected individuals were
born to consanguineous parents in all families. A com-
bined parametric LOD score of 7.46 was obtained for
a single region located on chromosome 11p11.2-q13.1698 The American Journal of Human Genetics 86, 696–706, May 14,between SNPs rs1346671 and rs490192 (Figure 1B),
deﬁning a shared critical interval of about 19.7 Mb. Subse-
quent analysis of microsatellite markers and inclusion of
additional family members conﬁrmed homozygous haplo-
types for the linked region in all affected individuals
(Figure 1C). We considered LRP4 as a highly relevant posi-
tional and functional candidate gene. No additional gene
from the critical region was tested. Sequencing of the 38
coding exons of LRP4 (Table S1) revealed different homo-
zygous mutations in affected individuals in each of the
six families. The mutations cosegregated with the disease
in the families and were not found in at least 250 healthy
control individuals. We found one donor splice-site muta-
tion, c.547þ1G>A (intron 6, CL-1), and ﬁve missense
mutations: c.479G>A (p.C160Y, exon 5, CL-2), c.409G>A
(p.D137N, exon 4, CL-3), c.1417C>T (p.L473F, exon 12,
CL-4), c.1585G>A (p.D529N, exon 13, CL-5), c.1345G>A
(p.D449N, exon 12, CL-6) (Figure 2A). All missense2010
mutations are located in the extracellular domains of LRP4
within highly conserved regions, as shown by LRP4 pro-
tein alignments of various species (Figure S1). p.C160Yand
p.D137N mutations lie within the ligand-binding (class A)
repeat-containing domain of the receptor, p.D449N and
p.L473F are located within calcium-binding epidermal
growth factor (EGF) repeats, and D529 is located within
the YWTD domain (Figure 2C).
We continued the molecular analysis of LRP4 in eight
additional CLS families (Figures 3A and 3C). In fami-
lies CL-9 and CL-10, we found the same homozygous
p.D529N mutation as identiﬁed before in the CL-5 family.
All three families originated from Turkey, and haplotype
analysis conﬁrmed that p.D529N is a common founder
mutation in Turkish CLS patients (Figure 3C). It is also
interesting to note that the p.D137N mutation is repeat-
edly found in CLS families from Egypt, as we could identify
a second family, CL-12, carrying this mutation. p.D137N
in both families was located on identical haplotypes
(Figure 3D), suggesting that p.D137N is a founder muta-
tion. Two additional missense mutations were found:
c.1382A>C (p.T461P, exon 11, CL-7) in a Jordanian patient
and c.3049T>C (p.C1017R, exon 22, CL-8) in a large CLS
family from Pakistan with six affected family members
(Figure 2B, Figure 3A). These mutations also cosegregated
with the disease, were not found in matched controls,
and were located in highly conserved regions (Figure S1).
Furthermore, no LRP4 mutation was found in two other
consanguineous CLS families, and haplotype analysis did
not show homozygosity of the LRP4 region in affected
individuals from both families, supporting the idea of
further locus heterogeneity (Figure 3B).
We found initial evidence for an impairment of LRP4
function as the underlying pathomechanism of CLS by
identifying compound-heterozygous splice-site mutations
in a typically affected fetus with CLS. Both mutations,
c.200-9G>A and c.4959G>C (Figure 2C), caused aber-
rantly spliced LRP4 transcripts (r.199_200insGATTCAG
and r.4952_4987del, respectively), and both mutations
lead to a truncated protein (Figures 4A and 4B).
LRP4 Mutations Cause Loss of Protein Function
To investigate whether the identiﬁed missense mutations
confer loss of function or whether they are functionally
hypomorphic with biochemically detectable residual pro-
tein activity, we analyzed the effect of ﬁve missense
mutations (p.D137N, p.C160Y, p.L473F, p.D449N, and
p.D529N) on the transduction and activation of canonical
Wnt signaling by using a Dual Luciferase Reporter Assay
in transiently transfected HEK293T cells. Consistent
with earlier ﬁndings,5 we found that WNT1 was able to
signiﬁcantly activate LRP6-mediated b-catenin signaling
and that additional coexpression of LRP4 potently antag-
onized this activation (Figure 5A). In contrast, coexpres-
sion of each of the ﬁve missense mutations abolished
the observed antagonistic LRP4 effect on LRP6-mediated
activation of Wnt/b-catenin signaling. Moreover, mutantThe AmeLRP4 receptors failed to be efﬁciently transported to the
plasma membrane, as shown by cell-surface biotinylation
(Figure 5B).
Discussion
We report the mapping of the CLS1 locus to chromosome
11p11.2-q13.1 and present convincing evidence that
mutations in the LRP4 gene cause CLS. Clinical ﬁndings
in our CLS patients showed that in addition to the well-
described distal limb malformations (ranging from total
to partial syndactyly and bone malformations of both
hands and feet), patients presented with facial features
such as prominent forehead, hypertelorism, downslanting
palpebral ﬁssures, and micrognathia. Previously, renal
hypoplasia has been reported in only one case16 and was
therefore not regarded as an associated trait of CLS. Our
ﬁnding that over 50% of CLS families present with renal
agenesis and/or hypoplasia adds kidney anomalies to the
clinical spectrum of CLS. In this context, it is interesting
to note that a subpenetrant phenotype of kidney agenesis
was observed in Lrp4 homozygous null mice. In the
Lrp4/ homozygous kidneys the ureteric budding is often
delayed, resulting in insufﬁcient stimulation of the mesen-
chyme. This results in destruction of prenephric mesen-
chymal structures, and no kidneys are formed (J. Herz,
personal communication). These ﬁndings clearly show
that Lrp4 has an important function for kidney develop-
ment in mice and humans.
Recently, murine LRP4 was shown to serve as a corecep-
tor for agrin in the formation of the neuromuscular junc-
tion.23 Mutations in genes encoding other members of
this complex have been associated with akinetic and
myasthenic syndromes in humans (MIM 288150 and
MIM 254300).24,25 Given that we did not observe a clini-
cally detectable neuromuscular phenotype in our CLS
patients, the role of LRP4 in the development and func-
tion of the neuromuscular junction in humans (as
opposed to mice) will require further investigation. In
the case that the LRP4 mutations found in CLS patients
are not complete loss-of-function mutations and do
have minor residual functionality in vivo, there could
be a different but overlapping phenotype caused by, for
example, homozygous nonsense mutations or deletions
in LRP4, and this could include neuromuscular symp-
toms.
The LRP4 mutations identiﬁed in our study are fre-
quently missense mutations, which are located in the large
extracellular domain of LRP4 within the ligand-binding
(class A) repeat-containing domain, calcium-binding EGF
repeats, and the YWTD domain of the receptor (Figure 2C).
These changes might cause structural alterations of the
extracellular LRP4 domain that interfere with normal fold-
ing and thus prevent the efﬁcient export of the protein
through the secretory pathway, but this hypothesis has
to be proven in future experimental studies. Our func-
tional analysis of ﬁve of the missense mutations clearlyrican Journal of Human Genetics 86, 696–706, May 14, 2010 699
Table 1. Clinical Findings in CLS Families Carrying LRP4 Mutations
Family Data CL-1 CL-2 CL-3 CL-4 CL-5 CL-6 CL-7 CL-8 CL-9 CL-10 CL-11 CL-12
Consanguinity þ þ þ þ þ þ þ þ þ þ - þ
No. of affected
individuals
1 1 3 3 1 2 1 6 2 2 1 1
Mutation c.547þ1G>A C160Y D137N L473F D529N D449N T461P C1017R D529N D529N c.200-9G>A,
c.4959G>C
D137N
Origin Pakistan Turkey Egypt Egypt Turkey Turkey Pakistan Jordan Turkey Turkey Turkey Egypt
Facial dysmorphism
Prominent forehead þ - þ þ - - þ þ þ þ þ þ
Hypertelorism þ - þ þ - - þ - þ - þ þ
Downsl. palpebral
ﬁssures
- - þ þ - - - þ - - - þ
Micro-, retrognathia þ - þ þ - - - þ - - þ þ
Teeth ﬁndings
Hypodontia - - - - - - - - þ - ? ?
Malar hypoplasia þ - þ þ - - þ þ - - þ þ
Enamel hypoplasia - - þ þ - - - - - - ? ?
Early loss of
permanent teeth
- - þ þ - ? - - ? ? ? ?
Upper limb ﬁndings
Typical syndactyly þ þ/ þ þ þ þ þ/ þ þ - þ þ
Short forearms þ - þ þ þ þ - - - - þ þ
Radius-ulnar
synostosis
þ - þ þ þ þ - - ? ? þ þ
Disorganized /
missing
metacarpals
and phalanges
þ þ þ þ þ þ þ þ þ þ þ þ
Fused metacarpals þ þ þ þ þ þ - þ þ þ þ þ
Nail aplasia þ þ/ þ þ þ þ þ þ þ - þ þ
Lower limb
ﬁndings
Syndactyly 2/3 2/3 þ þ 2/3–2/5 þ þ 1/2/3 R 2/3 2/3 1/2 þ
Tibia-ﬁbula
synostosis
- - - - - - - - - - - -
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Table 1. Continued
Family Data CL-1 CL-2 CL-3 CL-4 CL-5 CL-6 CL-7 CL-8 CL-9 CL-10 CL-11 CL-12
Disorganized /
missing metatarsals
and phalanges
- - þ þ þ/ - þ þ þ - -/þ þ
Nail aplasia /partial - - þ þ þ/ þ þ þ -/þ - þ þ
Kidney anomalies
Agenesis - - - - - - unilateral - bilateral bilateral bilateral -
Hypoplasia bilateral - - - - unilateral - unilateral - - - -
Ectopic
localization
- - - - - þ - þ - - - -
Additional
ﬁndings
Developmental
delay
- - þ - - - - - - mild gross
motor delay
? ?
Other bilateral
broad
hallux
valgus
anomaly
hypoplastic
scrotum
scoliosis,
hemivertebrae,
mixed-type
hearing loss
duplicated
distal
phalanges
of the ﬁrst
and second
toe, congenital
cataract
pulmonary
stenosis,
congenital hip
dislocation
hypothyroidis G1: died at
ﬁrst day
of life due
to bilateral
renal
agenesis
G2: medical
abortion
(20. GW),
bilateral
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agenesis
medical
abortion
(20. GW)
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patient
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Figure 2. Mutations Identified in LRP4
(A) Electropherograms of identiﬁed homozygous LRP4 mutations compared with heterozygous carrier and WT sequences (n.a., not
available).
(B) Electropherograms of identiﬁed compound-heterozygous splice-site mutations in LRP4 causing aberrant splicing and premature
protein truncation.
(C) Schematic view of LRP4 receptor domains and localization of identiﬁed CLS mutations.demonstrated a functional impairment of LRP4 mutant
proteins. LRP4 is important for control and modiﬁcation
of Wnt signaling by its antagonistic effect on LRP6-medi-
ated activation of WNT signaling (Figure 5C). This antago-
nistic function is completely lost in four out of ﬁve LRP4
mutants, as shown in our in a Dual Luciferase Reporter
Assay. The p.D137N mutant seems to show some residual
antagonistic function in the Reporter Assay experiment,
and the biotinylation experiments clearly demonstrated
that p.D137N mutant protein is not getting to the cell
surface. Whether a yet unknown function of LRP4, which
is not dependent on its membrane integration, could be
responsible for this residual function remains to be eluci-
dated.
We also found that WNT1 was able to signiﬁcantly acti-
vate LRP6-mediated b-catenin signaling, which is consis-
tent with earlier ﬁndings.7 We demonstrated that the
main reason for the loss-of-function effect is the failure
of mutant LRP4 receptors to be efﬁciently transported
to the plasma membrane. In addition, the heterozygous
splice-site mutations identiﬁed in the CL-11 fetus, c.200-
9G>A and c.4959G>C, caused aberrantly spliced LRP4
transcripts and premature protein truncations. Conclu-
sively, we suggest complete or near-complete loss of LRP4
function as the underlying pathogenetic mechanism of
CLS. As a result, developmental limb and kidney malfor-
mations in patients occur through amechanism that likely702 The American Journal of Human Genetics 86, 696–706, May 14,also involves excessive LRP6-mediated Wnt/b-catenin acti-
vation (Figure 5C).
It has been previously shown that Lrp4 dysfunction
also causes polysyndactyly in mice7 and syndactyly with
variable penetrance in bovines, termed mulefoot
disease.26 Lrp4 was shown to be expressed in the apical
ectodermal ridge (AER) in the developing limb bud,7
a structure important for coordination of patterning and
growth of the distal limb.8 Various signaling molecules
are secreted from the AER, such as sonic hedgehog
(Shh), bone morphogenic proteins (Bmps), ﬁbroblast
growth factors (Fgfs), and Wnts, and the complex interac-
tions of these signaling pathways are essential for normal
limb development.27,28 Extensive analysis of the limb
phenotype in Lrp4/ knockout mice showed that loss
of Lrp4 causes structural AER alterations as well as ectopic
expression of different key signaling molecules (e.g., Fgf8,
Bmp4, and Shh).7 Whether Lrp6 expression was upregu-
lated during limb development in the AER of Lrp4/
mice was not analyzed. Given the facts that (1) Lrp4
was described as an integrator of Wnt and Bmp
signaling,29 (2) Lrp4 has an antagonistic function on
Lrp6-mediated Wnt/b-catenin activation, and (3) Lrp6 is
critical for Wnt signaling during limb development in
mice,30 it is a reasonable working hypothesis that loss of
LRP4 during limb development in CLS patients could
lead to an overactivation of LRP6, which then causes2010
Figure 3. Additional CLS Families and Genetic Heterogeneity
(A) Pedigrees of additional CLS families.
(B) The LRP4 locus was excluded in families CL-13 and CL-14 by haplotype analysis.
(C and D) Identiﬁcation of an LRP4 founder mutation, p.D529N, in three Turkish CLS families (C) and of p.D137N in two families from
Egypt (D). Identical haplotypes are shown in red.altered Wnt signaling. Future approaches are needed to
show that knocking down LRP4 expression upregulates
Wnt/b-catenin in vivo.
In two CLS families, we did not ﬁnd LRP4 mutations,
and haplotype analysis did now show homozygosity in
affected individuals born to consanguineous parents.
In the CL-13 family with only a single affected individual,
homozygosity is only an assumption due to parental con-
sanguinity, but lack of homozygosity does not completely
exclude LRP4 as causative gene. In the CL-14 family, haplo-
type analysis of microsatellite markers as well as results
from 250K arrray analysis excluded common haplotypes
in both affected individuals, suggesting further locus het-
erogeneity in CLS. Future identiﬁcation of a causative
gene(s) in these families will highlight additional key pro-
teins for distal limb development.
We conclude that LRP4 function is required for the phys-
iological regulation of Wnt signaling, which is important
for normal limb and kidney development. HomozygousThe Ameloss of human LRP4 function causes syndactyly, synos-
tosis, and renal agenesis in Cenani-Lenz syndrome.Supplemental Data
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